Extended-Release Carbamazepine Capsules in Bipolar I Disorder: Profile Report

By Tracy Swainston Harrison   Keating Gillian M.  

American Journal of Drug Delivery, Vol. 4, Iss. 1, 2006-01 ,pp. : 51-55

Adis International

Access to resources Recommend Favorite

Extended-Release Carbamazepine Capsules as Monotherapy in Bipolar Disorder: Pooled Results from Two Randomised, Double-Blind, Placebo-Controlled Trials

By Weisler Richard H.   Hirschfeld Robert  

CNS Drugs, Vol. 20, Iss. 3, 2006-01 ,pp. : 219-231

Adis International

Access to resources Recommend Favorite

Extended-Release Carbamazepine Capsules: A Viewpoint by Richard H. Weisler

By Weisler Richard H.  

CNS Drugs, Vol. 19, Iss. 8, 2005-01 ,pp. : 717-718

Adis International

Access to resources Recommend Favorite

Cost Effectiveness of Adjunctive Quetiapine Fumarate Extended-Release Tablets with Mood Stabilizers in the Maintenance Treatment of Bipolar I Disorder

By >  

PharmacoEconomics, Vol. 28, Iss. 9, 2010-09 ,pp. : 751-764

Adis International

Access to resources Recommend Favorite

Simulated Fluctuations in Plasma Drug Concentrations for Patients Receiving Oxcarbazepine or Carbamazepine Extended-Release Capsules

By Ahmad Alaa  

Clinical Drug Investigation, Vol. 25, Iss. 10, 2005-01 ,pp. : 669-673

Adis International

Access to resources Recommend Favorite